Metabolomics Services Market Size to Reach US$ 6.92 Billion by 2034, Expanding at a CAGR of 22.39%

The metabolomics services market size is projected to reach US$ 6.92 billion by 2034 from US$ 1.12 billion in 2025. The market is anticipated to register a CAGR of 22.39% from 2026 to 2034. Rising use of metabolomics in drug discovery and biomarker research is supporting this growth. Growing demand for personalized medicine is also expanding the market.

Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00025127

Key Players Analysis:

BASF SE
The Metabolomics Innovation Centre (TMIC)
Creative Proteomics
BGI Genomics
RTI International
Afekta Technologies Ltd.
Fred Hutchinson Cancer Research Center
West Coast Metabolomics Center (UC Davis)
Molecular You

The metabolomics services market is one of the fastest-growing areas in life sciences, with revenue estimated to rise from US$ 1.12 Billion in 2025 to US$ 6.92 Billion by 2034 at a CAGR of 22.39%. Targeted and untargeted metabolomics services give researchers powerful ways to understand biological systems. Creative Proteomics, BGI Genomics and The Metabolomics Innovation Centre are leading with deep technical expertise.

Market Segmentation:

  • By Service Type (Targeted Metabolomics Service, Untargeted Metabolomics Service)
  • By Application (Pharmaceutical & Biotechnology Industry, Agritech, Environment)

Metabolomics Services Market Dynamics, Regional Analysis, and Future Outlook –

Market Challenges –

High cost of instruments and skilled personnel, lack of standardization in sample preparation and data analysis, and difficulty in reproducing results across laboratories remain significant barriers. Complex data interpretation, limited reference databases for many metabolites, data privacy concerns for clinical samples and competition from in-house capabilities at large organizations can restrain growth.

Market Opportunities –

Opportunities include expansion of clinical metabolomics for early disease detection, integration with genomics, proteomics and other multi-omics services, and use of AI and machine learning to interpret large metabolic datasets. Rising demand from agriculture, food and nutrition research, growth of personalized health programs and increasing outsourcing in emerging markets offer additional scope for service providers.

Regional Analysis –

North America leads because of strong research funding, a large base of pharmaceutical and academic customers and well-developed service providers. Europe follows with a robust life sciences ecosystem, while Asia-Pacific is expected to grow fastest as research investment rises and local providers expand in countries such as China, Japan, South Korea and India. Latin America and the Middle East and Africa remain smaller but are gradually developing.

Market Drivers –

Growth is driven by rising use of metabolomics in drug discovery, biomarker identification, precision medicine and nutrition research, along with increasing investment in life sciences R&D by pharmaceutical, biotechnology and academic institutions. Advances in mass spectrometry and NMR platforms, growing prevalence of metabolic and chronic diseases, and the tendency of research organizations to outsource complex analytical work to specialized providers also support demand.

Recent Industry Developments –

Recent activity includes launches of high-resolution mass spectrometry based targeted and untargeted metabolomics service panels, partnerships between service providers and pharmaceutical companies for biomarker studies, and expansion of laboratory capacity. Providers are also investing in cloud-based analysis tools and AI-driven interpretation to shorten turnaround times.

Future Analysis and Forecast –

The market is expected to grow strongly as metabolomics moves from research toward clinical and translational applications. Greater standardization, automation of workflows and integration with other omics data are likely to improve reliability and widen adoption over the forecast period.

Get Full Report Copy @ https://www.theinsightpartners.com/buy/TIPRE00025127

The metabolomics services market is recording robust scientific and commercial growth, propelled by the expanding utilization of untargeted and targeted metabolic profiling in biomarker discovery, precision medicine, drug safety screening, and agri-food characterization. Recent technological developments highlight the integration of high-resolution mass spectrometry, ultra-performance liquid chromatography, and high-field nuclear magnetic resonance spectroscopy with automated cloud bioinformatics pipelines. Service providers have established comprehensive annotated spectral metabolite libraries that enable rapid identification and quantitative validation of thousands of small molecules from clinical biofluids and tissue samples, drastically shortening analytical turnaround times for academic and pharmaceutical researchers.

About Us

The Insight Partners, we provide comprehensive analysis and insights into market trends that empower businesses to make informed decisions. Our reports are designed to equip stakeholders with the necessary information to navigate the complexities of various industries, including healthcare, technology, and finance. We are dedicated to delivering high-quality research that enables our clients to achieve their strategic objectives.

Contact Us:

Contact Person: Ankit Mathur

E-mail: ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876

    Leave a Comment